No abstract

Physiological stress associated with toluene exposure in batch cultures of Pseudomonas putida 54G was investigated. P. putida 54G cells were grown using a continuous vapor phase feed stream containing 150 ppmv or 750 ppmv toluene as the sole carbon and energy source. Cells were enumerated on non-selective (R2A agar plates) and a selective minimal medium incubated in the presence of vapor phase toluene (HCMM2). Differential recovery on the two media was used to evaluate bacterial stress, culturability and loss of toluene-degrading capability. A majority of the bacteria were reversibly stressed and could resume active colony formation on selective medium after passage on non-selective medium. A small fraction of the bacterial cells suffered an irreversible loss of toluene degradation capability and were designated as Tol- variants. Numbers of stressed organisms increased with duration of toluene exposure and toluene concentration and coincided with accumulation of metabolic intermediates from incomplete toluene degradation. Respiring cell numbers in the batch cultures decreased as injury increased, indicating a possible relationship between respiring and injured cells. Rate expressions for injury, for formation of Tol- variants and for growth of Tol- variants were determined by calibrating a theoretical model to the results obtained. These rate expressions can be used to calibrate bioreactor models, and provide a basis for better design and control of bioremediation systems.

The effects of prolonged toluene exposure and degradation on bacterial cultures of Pseudomonas putida 54G were investigated in three reactor systems: a batch suspended culture system, a bench-scale flat plate biofilm reactor, and a bench-scale packed column reactor. Humidified air containing 150 ppmv (toluene limiting) to 750 ppmv (oxygen limiting) toluene vapor was the sole source of carbon and energy supplied to these systems. Results from the suspended batch culture experiments were used to develop rate expressions and kinetic parameters for loss of culturability and of toluene degradative capacity. Experiments in the flat plate reactor were carried out to examine the effects of injury on biofilm structure and function. The packed column studies were performed under conditions relevant to field application, and confirmed results from the other two studies - that decreased culturability on toluene media correlated with decreased specific toluene degradation rate, particularly at higher toluene concentration.

Toluene degradation kinetics by biofilm and planktonic cells of Pseudomonas putida 54G were compared in this study. Batch degradation of 14C toluene was used to evaluate kinetic parameters for planktonic cells. The kinetic parameters determined for toluene degradation were: specific growth rate, μmax = 10.08 ± 1.2/day; half‐saturation constant, KS = 3.98 ± 1.28 mg/L; substrate inhibition constant, KI = 42.78 ± 3.87 mg/L. Biofilm cells, grown on ceramic rings in vapor phase bioreactors, were removed and suspended in batch cultures to calculate 14C toluene degradation rates. Specific activities measured for planktonic and biofilm cells were similar based on toluene degrading cells and total biomass. Long‐term toluene exposure reduced specific activities that were based on total biomass for both biofilm and planktonic cells. These results suggest that long‐term toluene exposure caused a large portion of the biomass to become inactive, even though the biofilm was not substrate limited. Conversely, specific activities based on numbers of toluene‐culturable cells were comparable for both biofilm and planktonically grown cultures. Planktonic cell kinetics are often used in bioreactor models to model substrate degradation and growth of bacteria in biofilms, a procedure we found to be appropriate for this organism. For superior bioreactor design, however, changes in cellular activity that occur during biofilm development should be investigated under conditions relevant to reactor operation before predictive models for bioreactor systems are developed. © 1997 John Wiley & Sons, Inc. Biotechnol Bioeng 53: 535–546, 1997.

No abstract